Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Borg

Showing results (51-60 of 224) with videos related to

Pageof 23
Sort By:
BMC Cancer|March 29, 2017
A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimenEmilie Lereclus, Mira Tout, Alban Girault, et al.
Transplant Immunology|May 31, 2011
Thymic function, anti-thymocytes globulins, and cancer after renal transplantationDidier Ducloux, Jamal Bamoulid, Cécile Courivaud, et al.
American Journal of Clinical Oncology|April 1, 2008
A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapiesErika Viel, Martin Frederico Demarchi, Loic Chaigneau, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 27, 2013
Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?Amélie Anota, Zeinab Hamidou, Sophie Paget-Bailly, et al.
Frontiers in Immunology|September 27, 2019
Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune ResponsesRomain Loyon, Marine Jary, Bérengère Salomé, et al.
International Journal of Cancer|November 22, 2019
Metronomic cyclophosphamide induces regulatory T cells depletion and PSA-specific T cells reactivation in patients with biochemical recurrent prostate cancerCaroline Laheurte, Antoine Thiery-Vuillemin, Fabien Calcagno, et al.
Cancer Immunology, Immunotherapy : CII|July 18, 2020
Economic evaluations of cancer immunotherapy: a systematic review and quality evaluationCharlotte Couchoud, Philippe Fagnoni, François Aubin, et al.
British Journal of Clinical Pharmacology|August 14, 2020
Exposure-response analysis of Raltitrexed assessing liver toxicityBernard Royer, Antonin Schmitt, Thierry Nguyen, et al.
Future Oncology (London, England)|May 20, 2021
Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohortJean-Philippe Metges, Dominique Genet, David Tougeron, et al.
Plos One|October 14, 2014
Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccineNegar Seyed, Tahereh Taheri, Charline Vauchy, et al.
Pageof 23

Showing results (51-60 of 224) with videos related to

Sort By:
Pageof 23
BMC Cancer|March 29, 2017
A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimenEmilie Lereclus, Mira Tout, Alban Girault, et al.
Transplant Immunology|May 31, 2011
Thymic function, anti-thymocytes globulins, and cancer after renal transplantationDidier Ducloux, Jamal Bamoulid, Cécile Courivaud, et al.
American Journal of Clinical Oncology|April 1, 2008
A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapiesErika Viel, Martin Frederico Demarchi, Loic Chaigneau, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 27, 2013
Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?Amélie Anota, Zeinab Hamidou, Sophie Paget-Bailly, et al.
Frontiers in Immunology|September 27, 2019
Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune ResponsesRomain Loyon, Marine Jary, Bérengère Salomé, et al.
International Journal of Cancer|November 22, 2019
Metronomic cyclophosphamide induces regulatory T cells depletion and PSA-specific T cells reactivation in patients with biochemical recurrent prostate cancerCaroline Laheurte, Antoine Thiery-Vuillemin, Fabien Calcagno, et al.
Cancer Immunology, Immunotherapy : CII|July 18, 2020
Economic evaluations of cancer immunotherapy: a systematic review and quality evaluationCharlotte Couchoud, Philippe Fagnoni, François Aubin, et al.
British Journal of Clinical Pharmacology|August 14, 2020
Exposure-response analysis of Raltitrexed assessing liver toxicityBernard Royer, Antonin Schmitt, Thierry Nguyen, et al.
Future Oncology (London, England)|May 20, 2021
Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohortJean-Philippe Metges, Dominique Genet, David Tougeron, et al.
Plos One|October 14, 2014
Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccineNegar Seyed, Tahereh Taheri, Charline Vauchy, et al.
Pageof 23